The company said reported sales rose 0.4% to $2.082 billion in Q3 2024, and organic sales rose 0.3%. GAAP EPS was $0.70, and adjusted EPS was $1.64.

1. 01

   The company said reported sales rose 0.4% to $2.082 billion in Q3 2024, and organic sales rose 0.3%. GAAP EPS was $0.70, and adjusted EPS was $1.64.

2. 02

   Solventum said GAAP operating income was $275 million for Q3, with an operating margin of 13.2% and a non-GAAP operating margin of 22.8%. The company cited lower gross margins, including the impact of the 3M supply agreement mark-up, along with public company stand-up costs and higher operating expenses tied to growth investments as factors behind the decline in GAAP and adjusted operating margin.

3. 03

   Solventum said cash from operations was $169 million and free cash flow was $76 million in Q3 2024. Purchases of property, plant and equipment totaled $93 million over the same period.

4. 04

   The company raised its full-year adjusted EPS outlook to $6.50 to $6.65 from $6.30 to $6.50, and its free cash flow outlook to $750M to $850M from $700M to $800M.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.